<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04229680</url>
  </required_header>
  <id_info>
    <org_study_id>1423170</org_study_id>
    <nct_id>NCT04229680</nct_id>
  </id_info>
  <brief_title>The Salty Gut: Effects of High Dietary Salt Intake on the Gut Microbiota</brief_title>
  <official_title>The Salty Gut: Effects of High Dietary Salt Intake on the Gut Microbiota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gut microbiota has a role in cardiovascular disease and recent findings in rodents show&#xD;
      dietary salt can negatively alter gut microbiota composition. High salt intake is a risk&#xD;
      factor for cardiovascular disease. Americans consume dietary salt in excess of Dietary&#xD;
      Guidelines and American Heart Association recommendations. The objective of this project is&#xD;
      to investigate the influence of high dietary salt consumption on the gut microbiota&#xD;
      composition in men and women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gut microbiota composition and function has an important role in host physiology. In general,&#xD;
      gut microbial diversity is positively correlated with health status. Recent evidence confirms&#xD;
      the role of gut dysbiosis in cardiovascular disease. Americans consume 50% more salt than the&#xD;
      amount recommended by the Dietary Guidelines and 130% more than recommended by the American&#xD;
      Heart Association. Excess salt intake is considered a modifiable risk factor for&#xD;
      cardiovascular disease. Changes in the gut microbiota composition followed by immune system&#xD;
      activation is reported with high salt intake in animals. In particular, abundance of&#xD;
      proinflammatory T helper 17 (Th17) cells increases with excess salt consumption. In contrast,&#xD;
      T regulatory (Treg) cells oppose Th17 cell action and may aid in reducing inflammation&#xD;
      associated with high salt intake, a hypothesis that has not yet been tested in humans. Only&#xD;
      one preliminary study assessed changes in gut bacterial composition with high salt intake in&#xD;
      humans, when only men were recruited. The study also found an increase in Th17 cell&#xD;
      abundance. Thus, the objective of this study is to investigate the influence of high salt&#xD;
      intake on the gut microbiota diversity and Th17 and Treg cell abundance in men and women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>All participants will complete each arm.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single-blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Gut microbiota diversity</measure>
    <time_frame>On day 10</time_frame>
    <description>The difference in gut microbiota diversity between the two arms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T cell profile</measure>
    <time_frame>On day 10</time_frame>
    <description>The difference in T regulatory and T helper 17 cells between each arm.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>High Salt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be counseled to consume a diet with 2,300 mg/d sodium which they will supplement with pills containing salt to achieve an intake of 6,900 mg/d sodium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recommended Salt</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will be counseled to consume a diet with 2,300 mg/d sodium which they will supplement with placebo pills.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Salt</intervention_name>
    <description>Consumption of pills containing table salt for 10 days.</description>
    <arm_group_label>High Salt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recommended Salt</intervention_name>
    <description>Consumption of pills containing dextrose for 10 days.</description>
    <arm_group_label>Recommended Salt</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  normal blood pressure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hypertension&#xD;
&#xD;
          -  cardiovascular disease&#xD;
&#xD;
          -  renal disease&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  cancer&#xD;
&#xD;
          -  current use of anti-inflammatory agents, glucocorticoids or other immune regulating&#xD;
             medications, or certain anti-depressants&#xD;
&#xD;
          -  history of intestinal surgery&#xD;
&#xD;
          -  inflammatory bowel disease, celiac disease, lactose intolerance, chronic pancreatitis&#xD;
             or other malabsorption disorder&#xD;
&#xD;
          -  antibiotic use in the past 3 months&#xD;
&#xD;
          -  prebiotic, probiotic, or antioxidant supplementation in the past 3 months&#xD;
&#xD;
          -  â‰¥10 lbs weight gain or loss in the past 6 months&#xD;
&#xD;
          -  use of tobacco products&#xD;
&#xD;
          -  highly trained endurance athletes&#xD;
&#xD;
          -  current pregnancy or lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon L Lennon, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Delaware</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Delaware</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19716</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dietary sodium</keyword>
  <keyword>Gut microbiota</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

